ANTI-CD19 CARS ARMED WITH NK RECEPTOR-DERIVED ACTIVATION DOMAINS DEMONSTRATE TO IMPROVE CAR-NK ANTITUMOR EFFECTOR FUNCTION AND ARE DIFFERENTIALLY ENHANCED BY DASATINIB MHD Santos, JTC Azevedo, RN Silvestre, RDT Calado, DT Covas, V Picanç-Castro

OPTIMIZATION OF A PROCESS FOR HIGH-YIELD LENTIVIRAL VECTOR PRODUCTION APPLIED TO CAR-T CELL GENERATION D.M.C. Fantacini, S.C.G. Lima, H. Brand, L.C. Batista, R. Cunha, D.T. Covas, L.E.B. Souza

CAR T-CELL Francesco Saglio